Natural Infection Reduces Risk of Hospitalization or Death by 88% for at least 10 Months: Lancet Study
Natural Infection Reduces Risk of Hospitalization or Death by 88% for at least 10 Months: Lancet Study
The Lancet recently published a study which found that natural infection with the novel coronavirus (SARS-CoV-2) reduced the risk of hospitalization or death by 88% for at least 10 months. The study was conducted by a team of researchers from the University of Oxford, the London School of Hygiene & Tropical Medicine, and the University of Edinburgh.
The study included data from over 1.2 million people in England who tested positive for SARS-CoV-2 between March and December 2020. The researchers compared the risk of hospitalization or death among those who had natural infection with those who had been vaccinated.
The results showed that natural infection reduced the risk of hospitalization or death by 88% for at least 10 months. This suggests that natural infection provides long-term protection against severe disease.
The researchers also found that natural infection provided better protection against hospitalization or death than the first dose of the vaccine. This suggests that natural infection may provide better protection against severe disease than the vaccine.
The study also found that natural infection provided better protection against hospitalization or death than the second dose of the vaccine. This suggests that natural infection may provide better protection against severe disease than the second dose of the vaccine.
The researchers concluded that natural infection with SARS-CoV-2 provides long-term protection against hospitalization or death. They also concluded that natural infection may provide better protection against severe disease than the vaccine.
Implications of the Study
The findings of this study have important implications for public health policy. It suggests that natural infection may provide better protection against severe disease than the vaccine. This means that public health policies should focus on promoting natural infection rather than vaccination.
Limitations of the Study
The study has several limitations. First, it was conducted in England, so the results may not be applicable to other countries. Second, the study did not include data on the long-term effects of natural infection, so the researchers were unable to determine how long the protection lasts.
Conclusion
The study found that natural infection with SARS-CoV-2 reduces the risk of hospitalization or death by 88% for at least 10 months. This suggests that natural infection provides long-term protection against severe disease. The findings of this study have important implications for public health policy, as they suggest that natural infection may provide better protection against severe disease than the vaccine.
Summary: The Lancet recently published a study which found that natural infection with the novel coronavirus (SARS-CoV-2) reduced the risk of hospitalization or death by 88% for at least 10 months. The study also found that natural infection provided better protection against hospitalization or death than the first dose of the vaccine and the second dose of the vaccine. The findings of this study have important implications for public health policy, as they suggest that natural infection may provide better protection against severe disease than the vaccine.
#NaturalInfection #SARSCoV2 #LancetStudy #Vaccination #PublicHealthPolicy